Concepedia

Maciej Kaliszczak

MK

18

Publications

570

Citations

16

H-Index

2010

Active since

Affiliations

Imperial College London(Current)

Hammersmith Hospital

Cancer Research UK Scotland Institute

Biogen (United States)

Cancer Research UK

Maciej Kaliszczak is an author at Imperial College London specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

2010–2023

18

Publications

18

A bioorthogonal <sup>68</sup>Ga-labelling strategy for rapid in vivo imaging

Helen L. Evans, Quang-Dé Nguyen, Laurence Carroll et al. · Chemical Communications · 2014 · 68 citations

, , +20

A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth

Maciej Kaliszczak, Sebastian Trousil, Ola Åberg et al. · British Journal of Cancer · 2013 · 60 citations · Full text

Development of a new epidermal growth factor receptor positron emission tomography imaging agent based on the 3-cyanoquinoline core: Synthesis and biological evaluation

Federica Pisaneschi, Quang-Dé Nguyen, Elham Shamsaei et al. · Bioorganic & Medicinal Chemistry · 2010 · 49 citations · Full text

, , +11

The HDAC6 inhibitor C1A modulates autophagy substrates in diverse cancer cells and induces cell death

Maciej Kaliszczak, Erich van Hechanova, Yunqing Li et al. · British Journal of Cancer · 2018 · 44 citations · Full text

The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth

Sebastian Trousil, Maciej Kaliszczak, Zachary T. Schug et al. · Oncotarget · 2016 · 43 citations · Full text

Rows per page

1–5 of 18